HCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting Takako Schaninger, MD Program Director.
HLA-B57 does not fully explain the ability of HIV controllers to clear HCV infection Alice K. Asher 1, RN, MS; Glenn-Milo Santos 1, MPH; Jennifer Evans,
Fuzzy Interpretation of Discretized Intervals Dr. Xindong Wu Andrea Porter April 11, 2002.
THE CHANGING FACE OF VIRAL HEPATITIS D. Robert Dufour, MD, FACB, FCAP Consultant Pathologist Attending, Liver Clinic VAMC, Washington DC Emeritus Professor.
Surveillance of hepatitis C Infection in France JC Desenclos, Département des Maladies Infectieuses Institut de Veille Sanitaire.
Hepatitis C Best Practice Guidelines Susan Thompson, RN, MPH September 2009.
The effect of Nucleic acid testing (NAT) in the safety of blood transfusions F. Kourgia, M. Vini, E. Zervou Blood Centre of University Hospital of Ioannina,
1 Advances in the treatment of chronic hepatitis C: Update to the Committee PEG-Intron/RebetolPEG-Intron/Rebetol.
In vitro expression of BVDV capsid protein Corpus Christi College, University of Oxford Glycobiology Institute, Department of Biochemistry KOR SHU CHAN.
Hepatitis C virus epidemiology Varsha Shete [email protected] Jeni [email protected].
Hepatitis C in Pakistan Rashid A. Chotani Assistant Professor & Director, The Global Infectious Disease Surveillance & Alert System The Johns Hopkins Bloomberg.
Hepatitis C: A New Era In Treatment And Cure Adam Deising, DO LCDR MC USN Director of Hepatology Department of Gastroenterology Naval Medical Center San.